|
Delayed
London S.E.
02:30:00 2026-10-20 EDT
|
5-day change | 1st Jan Change | ||
| 15.25 GBX | -.--% |
|
+2.35% | +154.17% |
| 10-20 | Bay Capital Looks to Acquire Biologic Medicines Developer Plenty Biologics | MT |
| 10-19 | Bay Capital Plc entered into heads of terms to acquire Plenty Biologics Limited for £40.7 million. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BAY CAPITAL PLC | Shell Companies | -.--% | +2.35% | +154.17% | +238.89% | -20.57% | 14.38M |
-
|
-
|
-
|
- Stock Market
- Stocks
- BAY Stock
- Charts Bay Capital Plc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
